1. Home
  2. Directory
  3. Alaska
  4. Anchorage
  5. Ophthalmology
  6. NPI Profile
  7. Prescriptions 1407895949

DAVID G CHAMBERLAIN MD
Prescription History 1407895949
Ophthalmology in Anchorage, AK


Quality Rating: 87.09 out of 100 score

NPI Status: Active since June 06, 2006

Contact Information

4315 DIPLOMACY DR
ATTN: SHERRY REEDY
ANCHORAGE, AK
ZIP 99508
Phone: (907) 729-3970
Fax: (907) 729-1542

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DAVID G CHAMBERLAIN MD, an active Ophthalmology specialist practicing in Anchorage, AK. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 193 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 79 claims alone.

Medication Index

C
L
M
P
T
No matching medications currently found on file.

Ciprofloxacin Hcl

Generic Formulation: Ciprofloxacin HclSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 18
30-Day Fills 19.0
Days Supply 200
AK State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills24.9
Peer Average Days Supply209
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $277.86 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.44

State Avg Cost Per Claim

$8.20

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A broad-spectrum antimicrobial carboxyfluoroquinoline.

Therapeutic Applications

This medication is used to treat eye infections. Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

Latanoprost

Generic Formulation: LatanoprostSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 79
30-Day Fills 81.0
Days Supply 2,080
AK State Average Benchmarks
Peer Average Claims53.0
Peer Average 30-Day Fills97.9
Peer Average Days Supply2,791
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 49.1% more claims than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,773.47 across this reporting matrix range.

Provider Avg Cost Per Claim

$47.77

State Avg Cost Per Claim

$26.71

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA.

Therapeutic Applications

Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.

Moxifloxacin

Generic Formulation: Moxifloxacin HclSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 29
30-Day Fills 29.0
Days Supply 317
AK State Average Benchmarks
Peer Average Claims39.0
Peer Average 30-Day Fills39.7
Peer Average Days Supply683
Conservative Utilization

This provider writes prescriptions for this formulation 25.6% less frequently than the standard regional baseline metric for practitioners inside AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,057.07 across this reporting matrix range.

Provider Avg Cost Per Claim

$36.45

State Avg Cost Per Claim

$29.20

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent.

Therapeutic Applications

This medication is a quinolone antibiotic used for eye infections.

Prednisolone Acetate

Generic Formulation: Prednisolone AcetateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 54
30-Day Fills 76.6
Days Supply 2,024
AK State Average Benchmarks
Peer Average Claims65.0
Peer Average 30-Day Fills86.2
Peer Average Days Supply2,247
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,736.61 across this reporting matrix range.

Provider Avg Cost Per Claim

$106.23

State Avg Cost Per Claim

$56.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain eye conditions due to inflammation or injury. Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids.

Timolol Maleate

Generic Formulation: Timolol MaleateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 13
30-Day Fills 16.4
Days Supply 464
AK State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills73.1
Peer Average Days Supply2,152
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 62.9% less volume than the regional standard for practitioners inside AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $932.07 across this reporting matrix range.

Provider Avg Cost Per Claim

$71.70

State Avg Cost Per Claim

$31.05

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor.

Therapeutic Applications

This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DAVID G CHAMBERLAIN MD provides transparency into local medical care patterns within Anchorage, AK.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Ophthalmology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.